What if I cannot afford Sarcoma treatment
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Financial Support for Sarcoma Treatment
I understand this is a serious concern. Sarcoma treatment—which may include surgery, radiation therapy, and chemotherapy—can be expensive. Here are concrete resources and strategies to explore:
Immediate Financial Assistance Programs
Pharmaceutical Assistance Programs
- Most chemotherapy drug manufacturers offer patient assistance programs (PAPs) that provide free or reduced-cost medications if you meet income requirements
- Examples include programs for doxorubicin, ifosfamide, gemcitabine, and other drugs used in sarcoma treatment (per NCCN Guidelines for Soft Tissue Sarcoma)
- Contact your oncologist's office—they often have staff who specialize in connecting patients to these programs
Hospital Financial Counseling
- Ask to speak with a financial counselor or patient advocate at your cancer center
- They can help with:
- Payment plans
- Charity care applications
- Hospital-specific assistance funds
- Sliding scale fees based on income
Broader Support Resources
National Organizations
- American Cancer Society (1-[phone removed]): Offers financial assistance, transportation help, and lodging for treatment
- National Association of Proton Beam Therapy (NAPBT): If radiation is recommended, they can help locate facilities
- CancerCare (1-[phone removed]): Provides financial assistance grants and co-payment help
- Patient Advocate Foundation: Offers co-payment assistance and financial aid
Clinical Trials
- Participating in clinical trials often means free treatment while contributing to sarcoma research
- Ask your oncologist if you're eligible for any trials studying new sarcoma therapies
Insurance-Related Strategies
- Appeal denials: If your insurance denies coverage, ask your doctor's office to submit an appeal with clinical justification
- Medicaid/Medicare: Check eligibility if you don't have insurance
- State programs: Many states have cancer-specific financial assistance programs
Questions to Ask Your Healthcare Team
- "Are there patient assistance programs available for the specific drugs you're recommending?"
- "Does your hospital have a financial counselor who can help me navigate costs?"
- "Are there clinical trials I might be eligible for that would cover treatment costs?"
- "What payment plans or charity care options are available?"
- "Can you help me understand what my insurance will and won't cover?"
Important Note
Don't let cost concerns prevent you from discussing treatment options with your oncologist. According to NCCN Guidelines for Soft Tissue Sarcoma, treatment decisions should be based on your specific diagnosis, stage, and medical situation—not financial barriers alone. Your care team can often work with you to find solutions.
Many sarcoma patients have successfully navigated financial challenges. Your oncology team has experience helping patients access the care they need.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Soft Tissue Sarcoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Sarcoma patients
Have your records handy? Upload them for a deeper, personalized analysis →